CLINICAL_TRIALS ClinicalTrials.gov record with results posted

A Phase 2, Randomized, Observer-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity in Relation to the Product Attributes of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Adults ≥50 to <65 Years of Age

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06508320
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-10-09T00:07:47.167565+00:00
Published At: 2026-10-08T00:00:00+00:00
Record Updated At: 2026-10-08
Results Posted At: 2026-10-08
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Influenza", "SARS-CoV-2"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-10-08"
protocolSection.identificationModule.nctId: "NCT06508320"
protocolSection.identificationModule.officialTitle: "A Phase 2, Randomized, Observer-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity in Relation to the Product Attributes of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Adults \u226550 to \u003c65 Years of Age"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2026-10-08"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.